Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model
PURPOSE. To determine the intravitreal pharmacokinetic properties and to study the systemic biodistribution characteristics of 1-124-labeled bevacizumab, ranibizumab, and aflibercept with positron emission tomography-computed tomography (PET/CT) imaging in a nonhuman primate model. METHODS. Three gr...
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Language: | en |
Published: |
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/627123 http://arizona.openrepository.com/arizona/handle/10150/627123 |